{"article_title": "Eli Lilly Loses Alimta Patent Case in Germany", "article_keywords": ["case", "alimta", "eli", "rare", "treats", "cancer", "revenue", "patent", "covers", "loses", "second", "selling", "germany", "total", "lilly", "ruled"], "article_url": "http://www.wsj.com/articles/eli-lilly-loses-alimta-patent-case-in-germany-1425651987", "article_text": "A German court on Friday ruled that Eli Lilly & Co. cannot prevent a competitor from selling a generic form of its key Alimta cancer drug once the patent expires this December.\n\nAlimta treats mesothelioma, a rare cancer linked to asbestos exposure. It generated 11% of the company\u2019s total revenue in 2012 and consists of two patents. The compound patent covers the basic chemical composition of the drugs. A second patent covers the...", "article_metadata": {"article.template": "snippet", "article.created": "2015-03-06T14:26:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "A German court ruled that Eli Lilly & Co. cannot prevent a competitor from selling a generic form of its key Alimta cancer drug once the patent expires this December.", "creator": "@chengela", "image": {"alt": "Eli Lilly Loses Alimta Patent Case in Germany", "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif"}, "title": "Eli Lilly Loses Alimta Patent Case in Germany", "site": "@WSJ", "card": "summary"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10510204943479844423404580501862462764540&headline=Eli%20Lilly%20Loses%20Alimta%20Patent%20Case%20in%20Germany&weburl=http://www.wsj.com/articles/SB10510204943479844423404580501862462764540"}}, "page.site.product": "WSJ", "keywords": "alimta,cancer drug,eli lilly,generic drugs,german court,germany,patent,pharma,ruling,Eli Lilly,LLY,Bristol-Myers Squibb,BMY,Merck,MRK,corporate crime,legal action,patents,corporate,industrial news,intellectual property,industrial property rights (patents,trademarks),political,general news,health,pharmaceuticals,cancer drugs,health care,life sciences,drugs,medication", "news_keywords": "alimta,cancer drug,eli lilly,generic drugs,german court,germany,patent,pharma,ruling,Eli Lilly", "article.headline": "Eli Lilly Loses Alimta Patent Case in Germany", "description": "A German court ruled that Eli Lilly & Co. cannot prevent a competitor from selling a generic form of its key Alimta cancer drug once the patent expires this December.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10510204943479844423404580501862462764540&headline=Eli%20Lilly%20Loses%20Alimta%20Patent%20Case%20in%20Germany&weburl=http://www.wsj.com/articles/SB10510204943479844423404580501862462764540", "user.type": "nonsubscriber", "article.page": "Business", "page.content.format": "responsive", "article.summary": "A German court ruled that Eli Lilly & Co. cannot prevent a competitor from selling a generic form of its key Alimta cancer drug once the patent expires this December.", "page.site": "wsj", "testkeys": "C", "article.published": "2015-03-06T14:26:00.000Z", "dj.asn": "i-f977", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"publisher": "https://www.facebook.com/wsj", "word_count": 299, "external_link_count": 1}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "A German court ruled that Eli Lilly & Co. cannot prevent a competitor from selling a generic form of its key Alimta cancer drug once the patent expires this December.", "title": "Eli Lilly Loses Alimta Patent Case in Germany", "url": "http://www.wsj.com/articles/eli-lilly-loses-alimta-patent-case-in-germany-1425651987", "image": {"width": 1200, "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif", "height": 630}, "locale": "en_US", "type": "article"}, "author": "Angela Chen", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Eli Lilly Loses Alimta Patent Case in Germany", "article.type": "Business", "article.id": "SB10510204943479844423404580501862462764540", "user.exp": "default", "article.updated": "2015-03-06T14:26:00.000Z"}, "_id": "\"57477af36914bd0286fcbb1f\"", "article_summary": "A second patent covers the...\nThe compound patent covers the basic chemical composition of the drugs.\nIt generated 11% of the company\u2019s total revenue in 2012 and consists of two patents.\nA German court on Friday ruled that Eli Lilly & Co. cannot prevent a competitor from selling a generic form of its key Alimta cancer drug once the patent expires this December.\nAlimta treats mesothelioma, a rare cancer linked to asbestos exposure."}